GENE ONLINE|News &
Opinion
Blog

2021-05-28| Technology

Screening for a brighter future: NHS Oncology Virtual Conference

by GeneOnline
Share To

10.20am BST

June 15, 2021

Registration Link: https://www.convenzis.co.uk/events/screening-for-a-brighter-future-nhs-oncology-virtual-conference/

Cancer affects us all. Survival in England is at a record high and patients’ experience of treatment and care has never been higher, but we won’t stop there. We want every person with cancer to have the very best diagnosis, treatment, and care. NHS England & Improvement

The NHS Long Term Plan set out a clear pathway for the improvement of cancer care, the aim being:

• Enable an extra 55,000 people each year to survive for five years or more following their cancer diagnosis.
• Three in four cancers (75%) will be diagnosed at an early stage.

This virtual Screening for a brighter future conference aims to showcase the forward-thinking and innovative initiatives that are already being implemented across the country. Here are a few examples:

Rapid Diagnostic Centres (RDCs): Rapid Diagnostic Centres (RDCs) are designed to speed up cancer diagnosis and support the NHS ambitions to achieve earlier diagnosis, with improved patient experience, for all patients with cancer symptoms or suspicious results.

The NHS Screening Programme: A £130 million national Radiotherapy Modernisation Fund has delivered the largest radiotherapy upgrade programme in 15 years. We have provided funding to replace or upgrade over 80 radiotherapy machines so that patients can have access to sustainable high-quality modern radiotherapy treatments wherever they live.

Proton Beam Therapy /(CAR-T) Therapy treatment to children: Proton beam therapy is a type of radiotherapy that uses a beam of high energy protons, which are small parts of atoms, rather than high energy x-rays (called photons) to treat specific types of cancer. CAR-T is a highly complex and innovative new treatment. CAR-T is a type of immunotherapy which involves collecting and using the patients’ own immune cells to treat their condition.

Providing personalised care and support interventions: The NHS Long Term Plan for Cancer stated that, ‘by 2021, where appropriate, every person diagnosed with cancer will have access to personalised care, including needs assessment, a care plan and health and wellbeing information and support’.

Our first Screening for a brighter future: NHS Oncology Virtual Conference will provide a timely opportunity to listen learn and engage with some of the UK’s leading Oncology experts while networking with like-minded peers.

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
Previewing AACR 2024 With Select Pre-Meeting Highlights
2024-03-28
AbbVie Boosts Global Manufacturing with $223 Million Expansion in Singapore
2024-01-29
JPM 2024: Pfizer’s Strategic Moves in the Obesity Drug Market and BioNTech’s Oncology Pipeline Expansion
2024-01-10
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top